🔗 Share this article

Texas Attorney General Paxton is taking legal action against the makers of acetaminophen, alleging the companies hid potential risks that the medication presented to pediatric cognitive development.

This legal action comes four weeks after Donald Trump advocated an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing J&J, which once produced the drug, the only pain reliever approved for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he said they "deceived the public by gaining financially from pain and promoting medication ignoring the dangers."

Kenvue states there is insufficient reliable data linking Tylenol to autism.

"These companies deceived for years, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, said.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a proven link between consuming acetaminophen and autism spectrum disorder."

Groups speaking for physicians and medical practitioners agree.

ACOG has declared acetaminophen - the primary component in acetaminophen - is a restricted selection for women during pregnancy to treat pain and fever, which can pose major wellness concerns if left untreated.

"In multiple decades of investigation on the utilization of acetaminophen in gestation, not a single reputable study has definitively established that the use of acetaminophen in any period of pregnancy results in neurodevelopmental disorders in offspring," the group stated.

This legal action mentions current declarations from the former administration in asserting the drug is allegedly unsafe.

Recently, Trump caused concern from health experts when he instructed pregnant women to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Kennedy, who supervises the FDA, had pledged in spring to conduct "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a limited time.

But authorities warned that identifying a sole reason of autism - thought by researchers to be the outcome of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a category of permanent neurological difference and impairment that impacts how persons perceive and interact with the surroundings, and is identified using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - asserts the manufacturer and J&J "intentionally overlooked and tried to quiet the science" around acetaminophen and autism.

This legal action seeks to make the firms "remove any promotional materials" that states acetaminophen is safe for expectant mothers.

This legal action mirrors the concerns of a group of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in 2022.

The court dismissed the lawsuit, declaring studies from the family's specialists was inconclusive.